Pain Therapeutics Market By Drug Class (Acetaminophen And Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Opioids, Anesthetics, Anticonvulsants, Corticosteroids, Antidepressants), By Pain Type (Nociceptive Pain, Neuropathic Pain, Psychogenic Pain) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Pain therapeutics are used to relieve pain either by stopping the pain signals or by altering the brain interpretation to these signals. Pain therapeutics have the ability to reduce pain intensity but do not treat the cause of the pain. The global pain therapeutics market is anticipated to grow significantly over the forecast period due to growing incidence of chronic and pain inducing illnesses, strong presence of ideal pipeline molecules, growing number of surgeries and rising number of musculoskeletal disease, inflammatory disease, trauma and injuries to the internal organ.   

The report titled “Pain Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers in-depth understanding into the overall pain therapeutics market size for duration 2015 to 2025. The report study covers detail analysis of pain therapeutics market segment based on drug class (acetaminophen and nonsteroidal anti-inflammatory drugs, opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants, other) and pain type (nociceptive pain, neuropathic pain and psychogenic pain).

This study covered in-depth the study of geographical market segment. Market size and forecast is studied for regional and country level markets such as Europe (Germany, United Kingdom, and Rest of Europe), North America (Canada and United States), Latin America (Mexico, Brazil and Rest of Latin America), Asia Pacific (China, japan and Rest of APAC), Middle East and Africa (GCC and Rest of Middle East and Africa).   

Along with the statistical information, qualitative information is also included in report for further understanding of current market position and future market scenario. To provide information related to ongoing trend of market, in-depth information related to pain therapeutics market drivers, opportunities and challenges are also included in this report. In addition, competitive environment, information related to the market positioning of key manufacturer and attractive investment proposition are also covered in this report.

Pain Therapeutics Market

For the purpose of this study, the global pain therapeutics market is categorized into:

  • North America
    • United States
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

Pain Therapeutics Market

Among the considered geographical segments, North America is current leader in global pain therapeutics market. The dominance of this region is majorly driven by United Sates due to key factors such as higher cost of pain relieving therapeutics, increase in number of affected population, growing number of pain management centers, higher demand for pain therapeutics, and easy availability of novel pain management drugs. According to the National Institutes of Health (NIH), approximately 100 million Americans, or one third of the United States population is affected with chronic pain. The key players in the North America continue to focus in research and development activities and tend to provide ideal pain management therapeutics in the near future. Expected launch of novel pain drugs such as GRO-12, REGN-475, KRN-5500, xpf-002, TV-45070, PF-04383119, AGN-203818 etc. would further assist market growth in North America. On other hand, Asia Pacific is anticipated to show significant market growth over the forecast period due increasing penetration of key players in emerging market such as China and India, increasing R&D investment, large pool of patients, growing healthcare expenditure and rising government funding and initiatives in healthcare systems.

Choose License Type
Published Date:  Dec 2017
Category:  Pharmaceuticals
Report ID:   58861
Report Format:   PDF
Pages:   120
Rating:    4.1 (50)
Connect With Us
+1-408-641-3282
24/7 Research Support